0001493152-23-029732.txt : 20230821
0001493152-23-029732.hdr.sgml : 20230821
20230821180013
ACCESSION NUMBER: 0001493152-23-029732
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230817
FILED AS OF DATE: 20230821
DATE AS OF CHANGE: 20230821
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aminov Erez
CENTRAL INDEX KEY: 0001986112
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41765
FILM NUMBER: 231190449
MAIL ADDRESS:
STREET 1: C/O MIRA PHARMACEUTICALS, INC.
STREET 2: 900 WEST PLATT STREET, SUITE 200
CITY: TAMPA
STATE: FL
ZIP: 33606-2173
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001904286
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 853354547
STATE OF INCORPORATION: FL
BUSINESS ADDRESS:
STREET 1: 855 N WOLFE STREET #623-6
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 813-369-5150
MAIL ADDRESS:
STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350
CITY: TAMPA
STATE: FL
ZIP: 33606
FORMER COMPANY:
FORMER CONFORMED NAME: Mira1a Therapeutics, Inc.
DATE OF NAME CHANGE: 20220112
4
1
ownership.xml
X0508
4
2023-08-17
0
0001904286
MIRA PHARMACEUTICALS, INC.
MIRA
0001986112
Aminov Erez
C/O MIRA PHARMACEUTICALS, INC.
855 N WOLFE ST., SUITE 200
BALTIMORE
MD
21205
1
1
0
0
CEO and Director
0
Stock Options
6.50
2023-08-17
4
A
0
150000
0
A
2033-08-17
Common Stock
150000
150000
D
The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on August 17, 2023.
The stock options were issued to the Reporting Person on August 17,2023, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. The award vests in full on August 17,2023.
/s/ Michelle Yanez, Attorney-in-Fact for Erez Aminov
2023-08-21